SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-013872
Filing Date
2019-09-09
Accepted
2019-09-09 16:45:36
Documents
7
Period of Report
2019-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43156
2 ex4-1.htm EX-4.1 162699
3 ex4-2.htm EX-4.2 86056
4 ex4-3.htm EX-4.3 79927
5 ex4-4.htm EX-4.4 82022
6 ex10-1.htm EX-10.1 151270
7 ex10-2.htm EX-10.2 89108
  Complete submission text file 0001493152-19-013872.txt   695641
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 191083502
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1